Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis

Karim Raza, L Mathsson, Christopher Buckley, Andrew Filer, J Rönnelid

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)
5 Downloads (Pure)

Abstract

Anti-CCP antibodies are very specific for the development of RA in patients with very early synovitis.[1] Their predictive value is underscored by their high weighting in an algorithm validated in patients with undifferentiated synovitis
Original languageEnglish
Pages (from-to)627-628
Number of pages2
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number3
DOIs
Publication statusPublished - 20 Oct 2009

Fingerprint

Dive into the research topics of 'Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis'. Together they form a unique fingerprint.

Cite this